HRMY - Harmony Biosciences Inc Qarzning balans kapitallashuviga nisbati
Harmony Biosciences (HRMY) uchun ushbu narxlar grafigi noyob miya patologiyalari terapiyalariga yo'naltirilgan loyihalarni sotib olish orqali hozirda yagona mahsulotga bo'lgan bog'liqligini kamaytirayotgan kompaniyaning dinamikasini aks ettiradi. Joriy ko'rsatkich 0.22 darajasida turibdi. Biznes patent himoyasi va noyob, bog'liqlikni keltirib chiqarmaydigan tarkibdan foydalanuvchi WAKIX dori vositasiga tayanadi; biroq, foyda barqarorligi ushbu dori vositasining bozor ulushi va yangi ishlanmalarning muvaffaqiyatiga bog'liq bo'lib qolmoqda.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_HRMY_-_Harmony-Biosciences_-_Debt-to-Net-Assets-Ratio "Harmony Biosciences Holdings, Inc. - HRMY Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Harmony Biosciences Inc (HRMY) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Harmony Biosciences|HRMY - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Harmony Pharma|HRMY - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Harmony Corp|HRMY - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Harmony Biosciences
Kompaniyaning jamlanma tahliliyoti:Harmony Biosciences (HRMY)
Harmony Biosciences (HRMY) kompaniyasida fundamental tayanchni topish uchun nevrologik portfelning rivojlanishi va patent himoyasi qarz mablag'laridan ko'ra qanchalik ko'p o'z kapitaliga tayanishini baholash muhimdir. GURU.Markets platformasida umumiy qarzdorlikning kapitalga nisbati dinamikasini tahlil qilish orqali investor sof aktivlarga nisbatan kreditor majburiyatlarining ulushini aniqlaydi, bunda past ko'rsatkichlar moliyaviy barqarorlikni tasdiqlaydi va chuqur pasayishlar xavfini minimallashtiradi.
Harmony Biosciences kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|VKTX - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati supernus.com|Balans kapitallashuviga qarzlar CPRX|Balans kapitallashuviga qarzlar DNLI (Denali)|Qarzning balans kapitallashuviga nisbati Biohaven Pharmaceutical|Amylyx Corp - Qarzning sof aktivlarga nisbati|TRVI: Qarzning balans kapitallashuviga nisbati|PRAX: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati AVXL|CBLL (CeriBell Inc) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Prothena Corporation (PRTA)|Qarzning balans qiymatiga nisbati Alector Therapeutics (ALEC)|Annexon, Inc. - Qarzning balans qiymatiga nisbati|Balans qiymatiga qarzlar omeros.com OMER|Qarzning balans qiymatiga nisbati Neurogene|Qarzning sof aktivlarga nisbati AC Immune S.A. ACIU|VYGR - Balans kapitallashuviga qarzlar|NMRA - Qarzning balans kapitallashuviga nisbati|Scilex Holding Company - Balans kapitallashuviga qarzlar|TVGN (tevogen.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati ACOG (Alpha Cognition Inc)|Balans qiymatiga qarzlar CGTX|IKT (Inhibikase) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Cassava Pharma (SAVA)|Assertio - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Coya Therapeutics Inc COYA|Balans kapitallashuviga qarzlar VTGN (VistaGen Therapeutics Inc)|OVID - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar ABOS|CRVO (CervoMed Corporation) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Alterity Therapeutics Ltd. (ATHE)|Qarzning balans qiymatiga nisbati Clene Nanomedicine|Balans kapitallashuviga qarzlar PEPG (PepGen Inc.)|Qarzning balans qiymatiga nisbati Jupiter Neurosciences, Inc. (JUNS)|RLMD: Balans kapitallashuviga qarzlar|Annovis Bio Corporation - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati GRCE (Grace Tx)|AIFF - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar anewmeds.com KLTO|NRSN (NeuroSense Therapeutics Ltd.) - Qarzning sof aktivlarga nisbati|RVPH - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati MTVA|Qarzning balans kapitallashuviga nisbati NRXS (NeurAxis, Inc.)|Qarzning balans qiymatiga nisbati heliusmedical.com HSDT|PASG: Qarzning balans qiymatiga nisbati|Neuphoria Therapeutics, Inc. - Balans qiymatiga qarzlar|Minerva Neurosciences Corp (NERV) - Qarzning balans kapitallashuviga nisbati|ATHA - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ADXN|Balans qiymatiga qarzlar Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PTIX|Pasithea Therapeutics (KTTA) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CRGT (cortigent.com)|ATXI: Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar brainstorm-cell.com BCLI|Balans kapitallashuviga qarzlar Cara Therapeutics (CARA)|CHRO - Qarzning sof aktivlarga nisbati|ELYM: Balans kapitallashuviga qarzlar|ITCI (Intra-Cellular Therapies, Inc.) - Balans kapitallashuviga qarzlar|LBPH - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati MRNS|Qarzning balans kapitallashuviga nisbati NKGN (NKGen Biotech)|Qarzning balans qiymatiga nisbati NRBO (NeuroBo Pharmaceuticals Inc)|SAGE: Qarzning balans kapitallashuviga nisbati|Synaptogenix, Inc - Balans qiymatiga qarzlar|Trevena, Inc. (TRVN) - Qarzning balans kapitallashuviga nisbati|Vigil Neuroscience (VIGL) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati WENA|Balans qiymatiga qarzlar Cerevel Therapeutics Inc